Insider Selling: Arteris, Inc. (NASDAQ:AIP) CEO Sells 60,584 Shares of Stock

Arteris, Inc. (NASDAQ:AIP) CEO K Charles Janac sold 60,584 shares of the business’s stock in a transaction on Thursday, December 26th. The stock was sold at an average price of $10.42, for a total value of $631,285.28. Following the completion of the transaction, the chief executive officer now directly owns 10,134,541 shares in the company, valued at approximately $105,601,917.22. This represents a 0.59 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink.

K Charles Janac also recently made the following trade(s):

• On Tuesday, December 17th, K Charles Janac sold 14,180 shares of Arteris stock. The shares were sold at an average price of $10.01, for a total value of $141,941.80.
• On Thursday, December 12th, K Charles Janac sold 17,856 shares of Arteris stock. The stock was sold at an average price of $10.12, for a total transaction of $180,702.72.
• On Tuesday, December 3rd, K Charles Janac sold 1,242 shares of Arteris stock. The stock was sold at an average price of $8.58, for a total transaction of $10,656.36.
• On Wednesday, October 2nd, K Charles Janac sold 5,520 shares of Arteris stock. The stock was sold at an average price of $7.18, for a total transaction of $39,633.60.

Arteris Trading Up 0.8 %

NASDAQ:AIP traded up $0.08 on Monday, hitting $10.35. 261,787 shares of the stock were exchanged, compared to its average volume of 169,906. The company has a debt-to-equity ratio of 0.30, a quick ratio of 1.16 and a current ratio of 1.16. Arteris, Inc. has a 52 week low of $4.83 and a 52 week high of $10.69. The stock has a market capitalization of $415.83 million, a price-to-earnings ratio of -10.78 and a beta of 1.25. The company’s 50-day moving average price is $8.50 and its 200 day moving average price is $7.95.

Institutional Investors Weigh In On Arteris

A number of institutional investors and hedge funds have recently modified their holdings of AIP. Bank of New York Mellon Corp acquired a new stake in Arteris during the 2nd quarter worth $580,000. Rhumbline Advisers boosted its position in shares of Arteris by 2,182.8% in the 2nd quarter. Rhumbline Advisers now owns 31,822 shares of the company’s stock worth $239,000 after purchasing an additional 30,428 shares during the last quarter. Renaissance Technologies LLC grew its stake in shares of Arteris by 6.1% during the second quarter. Renaissance Technologies LLC now owns 114,700 shares of the company’s stock worth $861,000 after purchasing an additional 6,600 shares during the period. CloudAlpha Capital Management Limited Hong Kong bought a new stake in Arteris in the second quarter valued at about $554,000. Finally, The Manufacturers Life Insurance Company bought a new position in Arteris during the second quarter worth about $86,000. 64.36% of the stock is owned by institutional investors.

Wall Street Analysts Forecast Growth

Separately, Rosenblatt Securities restated a “buy” rating and issued a $15.00 price objective on shares of Arteris in a research report on Wednesday, November 6th.

Arteris Company Profile

Arteris, Inc provides semiconductor interconnect intellectual property (IP) and System-on-Chip (Soc) Integration Automation software solutions (SIA) in the Americas, the Asia Pacific, Europe, and the Middle East. The company develops, licenses, and supports the on-chip interconnect fabric technology used in Soc designs and Network-on-Chip (NoC) interconnect IP.